Modern antihyperglycemic therapy: safety and efficacy of glimepiride

Current review analyzes pharmacological and clinical aspects of glimepiride from perspective of the evidence-based medicine. We aimedto determine position of glimepiride within modern antihyperglycemic dialectics of safety and efficacy. We also address cardioprotectiveproperties of glimeperide due t...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Lyudmila Alexandrovna Ruyatkina, Maksim Yur'evich Sorokin
Formato: article
Lenguaje:EN
RU
Publicado: Endocrinology Research Centre 2012
Materias:
Acceso en línea:https://doaj.org/article/7e0a54b9cd51417cbf3ed787ad5c41a0
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:7e0a54b9cd51417cbf3ed787ad5c41a0
record_format dspace
spelling oai:doaj.org-article:7e0a54b9cd51417cbf3ed787ad5c41a02021-11-14T09:00:17ZModern antihyperglycemic therapy: safety and efficacy of glimepiride2072-03512072-037810.14341/2072-0351-5525https://doaj.org/article/7e0a54b9cd51417cbf3ed787ad5c41a02012-06-01T00:00:00Zhttps://www.dia-endojournals.ru/jour/article/view/5525https://doaj.org/toc/2072-0351https://doaj.org/toc/2072-0378Current review analyzes pharmacological and clinical aspects of glimepiride from perspective of the evidence-based medicine. We aimedto determine position of glimepiride within modern antihyperglycemic dialectics of safety and efficacy. We also address cardioprotectiveproperties of glimeperide due to its anti-atherogenic activity, capacity to correct endothelial dysfunction and hemostatic system, as wellas absence of inhibitory effect on ischemic preconditioning.Lyudmila Alexandrovna RuyatkinaMaksim Yur'evich SorokinEndocrinology Research Centrearticlediabetes mellitus type 2sulphonylureaglimepiridecardioprotectionantihyperglycemic safetyNutritional diseases. Deficiency diseasesRC620-627ENRUСахарный диабет, Vol 15, Iss 2, Pp 89-97 (2012)
institution DOAJ
collection DOAJ
language EN
RU
topic diabetes mellitus type 2
sulphonylurea
glimepiride
cardioprotection
antihyperglycemic safety
Nutritional diseases. Deficiency diseases
RC620-627
spellingShingle diabetes mellitus type 2
sulphonylurea
glimepiride
cardioprotection
antihyperglycemic safety
Nutritional diseases. Deficiency diseases
RC620-627
Lyudmila Alexandrovna Ruyatkina
Maksim Yur'evich Sorokin
Modern antihyperglycemic therapy: safety and efficacy of glimepiride
description Current review analyzes pharmacological and clinical aspects of glimepiride from perspective of the evidence-based medicine. We aimedto determine position of glimepiride within modern antihyperglycemic dialectics of safety and efficacy. We also address cardioprotectiveproperties of glimeperide due to its anti-atherogenic activity, capacity to correct endothelial dysfunction and hemostatic system, as wellas absence of inhibitory effect on ischemic preconditioning.
format article
author Lyudmila Alexandrovna Ruyatkina
Maksim Yur'evich Sorokin
author_facet Lyudmila Alexandrovna Ruyatkina
Maksim Yur'evich Sorokin
author_sort Lyudmila Alexandrovna Ruyatkina
title Modern antihyperglycemic therapy: safety and efficacy of glimepiride
title_short Modern antihyperglycemic therapy: safety and efficacy of glimepiride
title_full Modern antihyperglycemic therapy: safety and efficacy of glimepiride
title_fullStr Modern antihyperglycemic therapy: safety and efficacy of glimepiride
title_full_unstemmed Modern antihyperglycemic therapy: safety and efficacy of glimepiride
title_sort modern antihyperglycemic therapy: safety and efficacy of glimepiride
publisher Endocrinology Research Centre
publishDate 2012
url https://doaj.org/article/7e0a54b9cd51417cbf3ed787ad5c41a0
work_keys_str_mv AT lyudmilaalexandrovnaruyatkina modernantihyperglycemictherapysafetyandefficacyofglimepiride
AT maksimyurevichsorokin modernantihyperglycemictherapysafetyandefficacyofglimepiride
_version_ 1718429589486698496